Novo Nordisk pens long-acting GLP-1 implant tech deal with Vivani Medical

Posted inMedical Technology

As Novo Nordisk looks for new ways to broaden its semaglutide GLP-1 franchise, the Danish drugmaker has signed a new deal with Californian medtech Vivani Medical to help.